Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
about
Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severityTolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis PatientsLessons learned from 2 decades of CAP therapy data: ways to improve patient managementResolution of localized chronic periodontitis associated with longstanding calculus depositsNew modalities in treating pneumococcal pneumonia.Macrolides for the long-term management of asthma--a meta-analysis of randomized clinical trials.Minocycline down-regulates topical mucosal inflammation during the application of microbicide candidatesCurrent concepts in host-microbe interaction leading to pneumococcal pneumoniaCorticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways.Macrolide antibiotics and survival in patients with acute lung injury.Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli UlcerTreatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection.Azithromycin for the treatment of eosinophilic nasal polyposis: Clinical and histologic analysisEffects of low-dose clarithromycin added to fluticasone on inflammatory markers and pulmonary function among children with asthma: A randomized clinical trialBartonellosis in cats: a role in uveitis?Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Emerging drugs for chronic obstructive pulmonary disease.Hematologic impact of antibiotic administration on patients taking clozapine.Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.The role of azithromycin in healthcare-associated pneumonia treatment.Clinical effect of azithromycin as an adjunct to non-surgical treatment of chronic periodontitis: a meta-analysis of randomized controlled clinical trials.Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.Bronchiectasis in China.Clinical case of botryomycome fulminant at the center of diagnostic and treatment of tuberculosis of Baleng (West - Cameroon).Direct and indirect anti-inflammatory effects of tulathromycin in bovine macrophages: inhibition of CXCL-8 secretion, induction of apoptosis, and promotion of efferocytosis.Clarithromycin stops lung function decline in airway-centered interstitial fibrosis.Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis.Reduction of RBL–2H3 cells degranulation by nitroaromatic compounds from a Bacillus strain associated to the Amazonian sponge Metania reticulataImmunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and FutureThe Association of Serum Neutrophil Markers and Acute Coronary SyndromeCommunity acquired pneumonia among adult patients at an Egyptian university hospital: bacterial etiology, susceptibility profile and evaluation of the response to initial empiric antibiotic therapy
P2860
Q21090921-18F263C8-514B-4973-9570-3AD84C567058Q28550641-26566B86-3445-4C4F-B238-568291DFFAE0Q31107743-48B30573-6FA5-466C-923B-ECE4A9C24C75Q33634494-0B61BB7E-FECE-4706-A183-B222CCBA6FE8Q34185386-FAEBB73F-85F8-4669-9ED3-DEFF60BDF61AQ34360438-09F3301D-A113-44D7-9FF0-EE154EF574AEQ34384880-923BBCAB-FEFB-4737-AD54-36566C224A32Q34540722-F53C2693-86C5-4C42-AB2A-5A2762593B81Q35857943-9CD59348-7246-4BC3-9F77-0129949DD3BAQ35929943-B8D5B906-A07B-427F-89EE-C02AF7CA40CEQ35994923-128DA013-6BFB-46CF-BC91-DD02A54B1008Q36406243-A1B7E0E9-D042-415D-A08F-AB777D4BF8E5Q37166129-C82835E3-33AD-47AF-85F3-33B547747A5FQ37230362-EAF4E91F-DDCC-4584-A113-81D54AF4003BQ37593071-C0156221-E403-49AA-AB7D-1821D50F8E79Q37933482-6DE490CE-579A-4BF9-9622-87938750C44AQ37959271-A73CACA4-2571-48F5-A903-AF6091992AD3Q37984088-7D5B79F9-1ED0-41D9-A56B-7A88F9E2796EQ38076430-45A586B3-CBAF-430C-AD66-5475E4E67956Q38085248-8B80667A-365F-43BB-B07C-F1B9A8EA44D2Q38217504-C2C95601-219D-4C63-B6A6-48D0399757F1Q38570217-BFDB174B-A22B-49CE-A419-C8504D1B7A80Q38585303-3FE0CA6E-7413-48A9-88DD-84A478FECC4FQ38740756-7D5850B9-24B4-4198-9FCB-B22AF4641DADQ39993355-2CFCAB63-02B3-4026-A174-65E23D22B9F6Q41384244-2EF1A3A9-91E7-4AEC-8176-A98276AABD64Q41453942-C6C06A9C-E2E1-4EB2-9F96-E3C225925E6BQ45896219-4DBBE5CD-7F9B-4B60-9AD7-ADB4CCF0AE42Q48189418-270AA9DB-D6EA-478A-A02E-9C29B42FF875Q53840621-F2A4A17A-B655-4A59-9401-4D05B7B6F457Q55410086-CC5B0F2D-02DB-491D-8C25-A0335F8FD5E9Q57023133-1637391F-EEED-40D2-B795-09D8000715AFQ57175340-14D5D2E7-3DDE-430C-A3DC-46B366D04234Q57315643-62F1ADFD-EF20-4A26-AD02-81DE3A5A8555Q59135084-76586D34-35EC-4998-B146-BBAB792E8548
P2860
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
@en
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
@nl
type
label
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
@en
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
@nl
prefLabel
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
@en
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
@nl
P2093
P356
P1433
P1476
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms
@en
P2093
C S de Graaff
J Altenburg
W G Boersma
P356
10.1159/000320319
P577
2010-08-21T00:00:00Z